I. Catry-Thomas

No Impact of Psychosocial Stress on Glioblastoma Development

H. Loiseau, V. Jecko, J. Engelhardt, 2021 .

Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective Study

D. Frappaz, F. Ghiringhelli, G. Ahle, 2022, AntiCancer Research.

Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.

F. Ducray, J. Honnorat, O. Chinot, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Radiotherapy of adult glial tumors: new developments and perspectives].

J. Maire, A. Huchet, I. Catry-Thomas, 2008, Revue neurologique.

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)

J. Honnorat, D. Frappaz, O. Chinot, 2018, The oncologist.

[Combination of etoposide, cisplatin and ifosfamide (VPH) in the salvage chemotherapy of relapsing or refractory aggressive malignant lymphoma. Study of 51 patients].

B. Hoerni, H. Eghbali, P. Soubeyran, 1994, Bulletin du Cancer.

[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study].

B. Chauffert, S. Taillibert, J. Honnorat, 2008, Revue neurologique.

PAINFUL PERIPHERAL NEUROPATHY AND CYTOMEGALOVIRUS PNEUMONIA IN AIDS

M. Dupon, J. Lacut, S. Leibowitz, 1989, The Lancet.